Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate a Accuracy of the AIVARIX AI-based Application in Detecting Signs C 1-2 Classes of CVD in Outpatients Seeking Consultancy of Phlebologists in the Russian Federation

NCT05612217 is registered in ClinicalTrials.gov with Servier Russia as lead sponsor.

NCT NCT05612217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05612217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate a Accuracy of the AIVARIX AI-based Application in Detecting Signs C 1-2 Classes of CVD in Outpatients Seeking Consultancy of Phlebologists in the Russian Federation
Lead sponsor
Servier Russia
Phase
Observational
Overall status
Completed
Start date
December 1, 2022
Completion date
April 1, 2024
Enrollment
433 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous disease, cvd